Avidian Wealth Solutions, LLC Biocryst Pharmaceuticals Inc Transaction History

Avidian Wealth Solutions, LLC

  • $2.13 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
SELL
$7.89 - $17.88 $244,590 - $554,280
-31,000 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$9.5 - $17.24 $9,500 - $17,240
1,000 Added 3.33%
31,000 $490,000
Q1 2021

May 05, 2021
BUY
$7.37 - $13.61 $221,100 - $408,300
30,000 New
30,000 $305,000

Others Institutions Holding BCRX

# of Institutions
279
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Avidian Wealth Solutions, LLC Portfolio

Follow Avidian Wealth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email